Aastrom Biosciences Inc. (ASTM) News

News for Aastrom Biosciences Inc. (ASTM)

Sector News | Topic News

Tue, Jan 24, 2012

8:20 AM

Breakthrough Therapy Using Cord Blood Banking Driving Stem Cell Industry - Marketwire

Mon, Jan 09, 2012

8:20 AM

Stem Cell Therapy From Aastrom Biosciences and Cytori Therapeutics Looks to Gain Ground in 2012 - Marketwire

Tue, Nov 22, 2011

4:07 PM

Aastrom Biosciences to Present at Piper Jaffray 23rd Annual Health Care Conference in New York City - Globe Newswire

Wed, Nov 16, 2011

8:16 AM

Breakthrough Stem Cell Therapy From Aastrom Biosciences and NeoStem Begins to Gain Ground - Marketwire

Mon, Nov 14, 2011

11:15 AM

Aastrom Reports Positive 12-Month Results from the RESTORE-CLI Phase 2 Clinical Trial for Ixmyelocel-T in Patients with Critical Limb Ischemia - Globe Newswire

Fri, Nov 11, 2011

4:05 PM

Aastrom Biosciences to Hold Research and Development Day Review for Investors on November 17, 2011 - Globe Newswire

Tue, Nov 08, 2011

4:05 PM

Aastrom Biosciences Reports Third Quarter 2011 Financial Results - Globe Newswire

Thu, Nov 03, 2011

9:05 AM

New York Academy of Sciences Symposium on Advances in Adult Stem Cell Therapy in Tissue Repair for Cardiovascular Diseases to Feature Aastrom Biosciences - Globe Newswire

Tue, Nov 01, 2011

4:05 PM

Final 12-Month Results From the Aastrom RESTORE-CLI Phase 2b Clinical Trial to be Presented at the American Heart Association Scientific Sessions 2011 on Monday, November 14, 2011 - Globe Newswire

Mon, Oct 31, 2011

4:05 PM

Webcast Alert: Aastrom to Host Third Quarter 2011 Investor Call on Tuesday, November 8, 2011 - Globe Newswire

Thu, Oct 13, 2011

4:11 PM

Aastrom Appoints Brian Gibson as Vice President, Finance - Globe Newswire

Mon, Oct 03, 2011

9:00 AM

Aastrom Granted European Composition-of-Matter Patent for Ixmyelocel-T - Globe Newswire

Fri, Sep 23, 2011

9:00 AM

Aastrom to Present at the Sixth Annual JMP Securities Healthcare Conference - Globe Newswire

Mon, Sep 19, 2011

9:00 AM

Aastrom Announces Positive 12-Month Safety and Efficacy Data From IMPACT-DCM Phase 2 Clinical Trial for Ixmyelocel-T in Treatment of Dilated Cardiomyopathy - Globe Newswire

Fri, Sep 16, 2011

9:00 AM

Aastrom Chief Scientific Officer Ronnda Bartel, PhD, to Present at the Cell Therapy Commercialization Summit - Globe Newswire

Wed, Sep 14, 2011

9:00 AM

Aastrom to Present 12-Month Data From the IMPACT-DCM Phase 2 Clinical Trial for Ixmyelocel-T in Treatment of Dilated Cardiomyopathy - Globe Newswire

Thu, Sep 08, 2011

9:00 AM

Aastrom to Present at the 13th Annual Rodman & Renshaw Healthcare Conference - Globe Newswire

Thu, Sep 01, 2011

9:01 AM

Aastrom to Present at the Stifel Nicolaus Healthcare Conference - Globe Newswire

Mon, Aug 15, 2011

4:01 PM

Aastrom Biosciences Reports Operating Results for the Quarter and Six Months Ended June 30, 2011 - Globe Newswire

Thu, Aug 11, 2011

4:01 PM

Aastrom Announces Adoption of Shareholder Rights Plan - Globe Newswire

Fri, Aug 05, 2011

8:16 AM

MultiCell Technology and Aastrom Biosciences Aim to Shatter Stem Cell Myths - Marketwire

Tue, Jul 26, 2011

7:00 AM

Aastrom Announces Agreement From FDA on Special Protocol Assessment for Phase 3 Clinical Trial in No-Option Critical Limb Ischemia Patients - Globe Newswire

Thu, Jun 23, 2011

4:15 PM

Journal of Vascular Surgery Publishes Interim Results of RESTORE-CLI Phase 2b Clinical Trial - Globe Newswire

Tue, Jun 21, 2011

4:15 PM

Aastrom Establishes Independent Steering Committee for REVIVE Phase 3 CLI Clinical Program - Globe Newswire

Thu, Jun 16, 2011

4:39 PM

Aastrom Files At-the-Market Offering and New Shelf Registration Statement - Globe Newswire

First

1 2

Last